<bill session="117" type="h" number="3125" updated="2023-03-08T19:58:39Z">
  <state datetime="2021-05-18T13:24:04-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2021-05-18T13:24:04-04:00"/>
  </status>
  <introduced datetime="2021-05-11"/>
  <titles>
    <title type="display">COVID-19 Emergency Medical Supplies Enhancement Act of 2021</title>
    <title type="short" as="passed house">COVID-19 Emergency Medical Supplies Enhancement Act of 2021</title>
    <title type="short" as="passed house">COVID&#226;&#8364;&#8220;19 Emergency Medical Supplies Enhancement Act of 2021</title>
    <title type="short" as="introduced">COVID&#226;&#8364;&#8220;19 Emergency Medical Supplies Enhancement Act of 2021</title>
    <title type="official" as="introduced">To enhance authorities under the Defense Production Act of 1950 to respond to the COVID-19 emergency, to provide additional oversight of such authorities, and for other purposes.</title>
    <title type="official" as="introduced">To enhance authorities under the Defense Production Act of 1950 to respond to the COVID&#226;&#8364;&#8220;19 emergency, to provide additional oversight of such authorities, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="V000130"/>
  <cosponsors>
    <cosponsor bioguide_id="G000582" joined="2021-05-17"/>
    <cosponsor bioguide_id="H001072" joined="2021-05-11"/>
    <cosponsor bioguide_id="R000577" joined="2021-05-17"/>
    <cosponsor bioguide_id="T000479" joined="2021-05-17"/>
  </cosponsors>
  <actions>
    <action datetime="2021-05-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-05-11" state="REFERRED">
      <text>Referred to the House Committee on Financial Services.</text>
    </action>
    <action datetime="2021-05-18T13:13:20-04:00">
      <text>Mr. Cleaver moved to suspend the rules and pass the bill.</text>
    </action>
    <action datetime="2021-05-18T13:13:41-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H2456-2458" label="consideration"/>
    </action>
    <action datetime="2021-05-18T13:13:45-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 3125.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2021-05-18T13:24:04-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill Agreed to by voice vote.</text>
      <reference ref="CR H2456-2457" label="text"/>
    </vote>
    <action datetime="2021-05-18T13:24:06-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2021-05-19">
      <text>Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSBK" name="Senate Banking, Housing, and Urban Affairs" subcommittee="" activity="Referral"/>
    <committee code="HSBA" name="House Financial Services" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Government operations and politics"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Government lending and loan guarantees"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Manufacturing"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Military procurement, research, weapons development"/>
    <term name="Public contracts and procurement"/>
    <term name="Public-private cooperation"/>
    <term name="Small business"/>
    <term name="Strategic materials and reserves"/>
    <term name="Worker safety and health"/>
  </subjects>
  <amendments/>
  <summary date="2021-06-23T18:21:24Z" status="Passed House">COVID-19 Emergency Medical Supplies Enhancement Act of 2021

This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies.

The bill makes loans under the DPA subject to certain notification requirements.

A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.</summary>
</bill>
